08 Apr. 2019

BIOVERSYS IS FEATURED IN A FORBES FRANCE SPECIAL

BioVersys is featured in a Forbes France special presenting 10 Swiss SME's to watch. A link to the English version can be found at the bottom of th...


08 Apr. 2019

ARE NOVEL ANTIBIOTICS WORTH INVESTING IN?


08 Apr. 2019

PRESS RELEASE - NEW CDO AT BIOVERSYS - DR. GLENN DALE

BioVersys is pleased to announce the appointment of Dr. Glenn Dale as Chief Development Officer as of February 1st, 2019.


08 Apr. 2019

FRESH FUNDS TO FUEL THE FIGHT AGAINST DRUG-RESISTANT BACTERIA

BioVersys together with BioSystems Technology and Voxcan announced funding - € 840,000 over a 3-year period - by Eurostars for IMPACT2, a new translat...